Stock NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Navidea Biopharmaceuticals, Inc.

Equities

NAVB

US63937X2027

Delayed OTC Markets
Other stock markets
 16:45:48 20/05/2024 BST 		5-day change 1st Jan Change
0.03 USD +15.38% Intraday chart for Navidea Biopharmaceuticals, Inc. -14.29% -45.65%
2023 Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding CI
2023 Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NAVIDEA BIOPHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
+15.38%-14.29%-45.65%-71.15%-97.92% 3M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NAVB Stock
  4. Charts Navidea Biopharmaceuticals, Inc.
  5. Comparison Chart